retatrutide joint pain just set a new bar. 🧬 In TRIUMPH-4, Lilly's triple agonist delivered ~28.7% body-weight loss (~71 lbs at 68 weeks) and major knee OA relief (WOMAC ↓ 4.5 points, 75.8%) Eli Lilly's Next-Gen Obesity Drug

It works by targeting GLP-1 receptors to help people feel fuller while eating less throughout the day

Stay Upright Avoid lying flat after eating

At Alevia, we're committed to integrating this evolving evidence into comprehensive, multidisciplinary care

Packaging can differ from U.S

A: Many people assess skin changes over 6 to 12 weeks of consistent use, since collagen-related changes are gradual

(2007) 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes